Cargando…

Emerging Indications for Interventional Oncology: Expert Discussion on New Locoregional Treatments

SIMPLE SUMMARY: Interventional oncology provides minimally invasive alternatives to many traditional medical and surgical treatments, offering a potential cure, control, or palliative care for many types of cancer patients. The aim of this article is to comprehensively review new indications for loc...

Descripción completa

Detalles Bibliográficos
Autores principales: Iezzi, Roberto, Gangi, Afshin, Posa, Alessandro, Pua, Uei, Liang, Ping, Santos, Ernesto, Kurup, Anil N., Tanzilli, Alessandro, Tenore, Lorenzo, De Leoni, Davide, Filippiadis, Dimitrios, Giuliante, Felice, Valentini, Vincenzo, Gasbarrini, Antonio, Goldberg, Shraga N., Meijerink, Martijn, Manfredi, Riccardo, Kelekis, Alexis, Colosimo, Cesare, Madoff, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818393/
https://www.ncbi.nlm.nih.gov/pubmed/36612304
http://dx.doi.org/10.3390/cancers15010308
_version_ 1784864974807498752
author Iezzi, Roberto
Gangi, Afshin
Posa, Alessandro
Pua, Uei
Liang, Ping
Santos, Ernesto
Kurup, Anil N.
Tanzilli, Alessandro
Tenore, Lorenzo
De Leoni, Davide
Filippiadis, Dimitrios
Giuliante, Felice
Valentini, Vincenzo
Gasbarrini, Antonio
Goldberg, Shraga N.
Meijerink, Martijn
Manfredi, Riccardo
Kelekis, Alexis
Colosimo, Cesare
Madoff, David C.
author_facet Iezzi, Roberto
Gangi, Afshin
Posa, Alessandro
Pua, Uei
Liang, Ping
Santos, Ernesto
Kurup, Anil N.
Tanzilli, Alessandro
Tenore, Lorenzo
De Leoni, Davide
Filippiadis, Dimitrios
Giuliante, Felice
Valentini, Vincenzo
Gasbarrini, Antonio
Goldberg, Shraga N.
Meijerink, Martijn
Manfredi, Riccardo
Kelekis, Alexis
Colosimo, Cesare
Madoff, David C.
author_sort Iezzi, Roberto
collection PubMed
description SIMPLE SUMMARY: Interventional oncology provides minimally invasive alternatives to many traditional medical and surgical treatments, offering a potential cure, control, or palliative care for many types of cancer patients. The aim of this article is to comprehensively review new indications for locoregional interventional oncology treatments and summarize the expert discussion and report from the “MIOLive Meets SIO” (Society of Interventional Oncology) session during the last Mediterranean Interventional Oncology Live congress held in Rome, Italy. ABSTRACT: Interventional oncology (IO) employs image-guided techniques to perform minimally invasive procedures, providing lower-risk alternatives to many traditional medical and surgical therapies for cancer patients. Since its advent, due to rapidly evolving research development, its role has expanded to encompass the diagnosis and treatment of diseases across multiple body systems. In detail, interventional oncology is expanding its role across a wide spectrum of disease sites, offering a potential cure, control, or palliative care for many types of cancer patients. Due to its widespread use, a comprehensive review of the new indications for locoregional procedures is mandatory. This article summarizes the expert discussion and report from the “MIOLive Meet SIO” (Society of Interventional Oncology) session during the last MIOLive 2022 (Mediterranean Interventional Oncology Live) congress held in Rome, Italy, integrating evidence-reported literature and experience-based perceptions. The aim of this paper is to provide an updated review of the new techniques and devices available for innovative indications not only to residents and fellows but also to colleagues approaching locoregional treatments.
format Online
Article
Text
id pubmed-9818393
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98183932023-01-07 Emerging Indications for Interventional Oncology: Expert Discussion on New Locoregional Treatments Iezzi, Roberto Gangi, Afshin Posa, Alessandro Pua, Uei Liang, Ping Santos, Ernesto Kurup, Anil N. Tanzilli, Alessandro Tenore, Lorenzo De Leoni, Davide Filippiadis, Dimitrios Giuliante, Felice Valentini, Vincenzo Gasbarrini, Antonio Goldberg, Shraga N. Meijerink, Martijn Manfredi, Riccardo Kelekis, Alexis Colosimo, Cesare Madoff, David C. Cancers (Basel) Review SIMPLE SUMMARY: Interventional oncology provides minimally invasive alternatives to many traditional medical and surgical treatments, offering a potential cure, control, or palliative care for many types of cancer patients. The aim of this article is to comprehensively review new indications for locoregional interventional oncology treatments and summarize the expert discussion and report from the “MIOLive Meets SIO” (Society of Interventional Oncology) session during the last Mediterranean Interventional Oncology Live congress held in Rome, Italy. ABSTRACT: Interventional oncology (IO) employs image-guided techniques to perform minimally invasive procedures, providing lower-risk alternatives to many traditional medical and surgical therapies for cancer patients. Since its advent, due to rapidly evolving research development, its role has expanded to encompass the diagnosis and treatment of diseases across multiple body systems. In detail, interventional oncology is expanding its role across a wide spectrum of disease sites, offering a potential cure, control, or palliative care for many types of cancer patients. Due to its widespread use, a comprehensive review of the new indications for locoregional procedures is mandatory. This article summarizes the expert discussion and report from the “MIOLive Meet SIO” (Society of Interventional Oncology) session during the last MIOLive 2022 (Mediterranean Interventional Oncology Live) congress held in Rome, Italy, integrating evidence-reported literature and experience-based perceptions. The aim of this paper is to provide an updated review of the new techniques and devices available for innovative indications not only to residents and fellows but also to colleagues approaching locoregional treatments. MDPI 2023-01-02 /pmc/articles/PMC9818393/ /pubmed/36612304 http://dx.doi.org/10.3390/cancers15010308 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Iezzi, Roberto
Gangi, Afshin
Posa, Alessandro
Pua, Uei
Liang, Ping
Santos, Ernesto
Kurup, Anil N.
Tanzilli, Alessandro
Tenore, Lorenzo
De Leoni, Davide
Filippiadis, Dimitrios
Giuliante, Felice
Valentini, Vincenzo
Gasbarrini, Antonio
Goldberg, Shraga N.
Meijerink, Martijn
Manfredi, Riccardo
Kelekis, Alexis
Colosimo, Cesare
Madoff, David C.
Emerging Indications for Interventional Oncology: Expert Discussion on New Locoregional Treatments
title Emerging Indications for Interventional Oncology: Expert Discussion on New Locoregional Treatments
title_full Emerging Indications for Interventional Oncology: Expert Discussion on New Locoregional Treatments
title_fullStr Emerging Indications for Interventional Oncology: Expert Discussion on New Locoregional Treatments
title_full_unstemmed Emerging Indications for Interventional Oncology: Expert Discussion on New Locoregional Treatments
title_short Emerging Indications for Interventional Oncology: Expert Discussion on New Locoregional Treatments
title_sort emerging indications for interventional oncology: expert discussion on new locoregional treatments
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818393/
https://www.ncbi.nlm.nih.gov/pubmed/36612304
http://dx.doi.org/10.3390/cancers15010308
work_keys_str_mv AT iezziroberto emergingindicationsforinterventionaloncologyexpertdiscussiononnewlocoregionaltreatments
AT gangiafshin emergingindicationsforinterventionaloncologyexpertdiscussiononnewlocoregionaltreatments
AT posaalessandro emergingindicationsforinterventionaloncologyexpertdiscussiononnewlocoregionaltreatments
AT puauei emergingindicationsforinterventionaloncologyexpertdiscussiononnewlocoregionaltreatments
AT liangping emergingindicationsforinterventionaloncologyexpertdiscussiononnewlocoregionaltreatments
AT santosernesto emergingindicationsforinterventionaloncologyexpertdiscussiononnewlocoregionaltreatments
AT kurupaniln emergingindicationsforinterventionaloncologyexpertdiscussiononnewlocoregionaltreatments
AT tanzillialessandro emergingindicationsforinterventionaloncologyexpertdiscussiononnewlocoregionaltreatments
AT tenorelorenzo emergingindicationsforinterventionaloncologyexpertdiscussiononnewlocoregionaltreatments
AT deleonidavide emergingindicationsforinterventionaloncologyexpertdiscussiononnewlocoregionaltreatments
AT filippiadisdimitrios emergingindicationsforinterventionaloncologyexpertdiscussiononnewlocoregionaltreatments
AT giuliantefelice emergingindicationsforinterventionaloncologyexpertdiscussiononnewlocoregionaltreatments
AT valentinivincenzo emergingindicationsforinterventionaloncologyexpertdiscussiononnewlocoregionaltreatments
AT gasbarriniantonio emergingindicationsforinterventionaloncologyexpertdiscussiononnewlocoregionaltreatments
AT goldbergshragan emergingindicationsforinterventionaloncologyexpertdiscussiononnewlocoregionaltreatments
AT meijerinkmartijn emergingindicationsforinterventionaloncologyexpertdiscussiononnewlocoregionaltreatments
AT manfrediriccardo emergingindicationsforinterventionaloncologyexpertdiscussiononnewlocoregionaltreatments
AT kelekisalexis emergingindicationsforinterventionaloncologyexpertdiscussiononnewlocoregionaltreatments
AT colosimocesare emergingindicationsforinterventionaloncologyexpertdiscussiononnewlocoregionaltreatments
AT madoffdavidc emergingindicationsforinterventionaloncologyexpertdiscussiononnewlocoregionaltreatments